Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute lymphoblastic leukaemia in elderly patients: biological characteristics and therapeutic approaches.

Drugs & aging - 1 Jan 2004

Robak Tadeusz

Abstract excerpt

Acute lymphoblastic leukaemia (ALL) is a rare disease in the elderly. The prevalence of ALL in patients >60 years of age is reported to be between 16% and 31% of all adult cases. The biology of ALL in older patients seems to be significantly different from that in younger patients and may, at least in part, explain poor treatment outcome. Immunophenotyping and cytogenetic characteristics are among the most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Antineoplastic Agents
Share to Benzamides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imatinib Mesylate

Share to Incidence

Share to Piperazines

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Pyrimidines

Source

Identifiers

PMID: 15382958
DOI: 10.2165/00002512-200421120-00003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute lymphoblastic leukaemia in elderly patients: biological characteristics and therapeutic approaches.PMID 15382958Read ↗

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.Semantic proximity Read ↗

Acute Myeloid Leukemia: Aging and EpigeneticsSemantic proximity Read ↗

Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.Semantic proximity Read ↗

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.Semantic proximity Read ↗

The biology and therapy of adult acute lymphoblastic leukemia.Semantic proximity Read ↗

Acute lymphocytic leukemia in adults: a retrospective study and analysis of current management options.Semantic proximity Read ↗

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-BSemantic proximity Read ↗

Towards targeted therapy for infant acute lymphoblastic leukaemia.Semantic proximity Read ↗

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 studySemantic proximity Read ↗

How can we improve on the already impressive results in pediatric ALL?Semantic proximity Read ↗

High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALLSemantic proximity Read ↗

AML in the Elderly - When less may be more.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.